Zhen Feng on Muck Rack

Zhen Feng

China
As seen in: Nature, Wiley Online Library, PLOS, BMJ Open, MDPI, BMC Genomics, Science Magazine, Royal Society of Chemistry, Canadian Journal of Infectious Diseases & Medical Microbiology, Dove Medical Press and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Zhen

Contact Zhen, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Pillars of exclusivity: Regulatory data protection regime for pharma in China

|
By Zhen Feng, Stefaan Meuwissen
| JD Supra
[co-author: Mingjia Deng] Key takeaways China’s new Implementation Measures make regulatory data protection a practical and enforceable exclusivity tool, but only if companies actively secure it at the NDA stage and align global filing strategies with China. A critical, short transitional window applies to pipeline products already under review, requiring filings by the beginning of June 2026, and failure to act within this deadline will result in a permanent loss of data protection rights.
Open in Who Shared Issue with article?

Pillars of exclusivity: Regulatory data protection regime for pharma in China

|
By Zhen Feng, Stefaan Meuwissen, Jessie Xie
| Westlaw Today
China's new Implementation Measures make regulatory data protection a practical and enforceable exclusivity tool, but only if companies actively secure it at the NDA stage and align global filing strategies with...
Open in Who Shared Issue with article?

Pillars of pharmaceutical IP: Regulatory exclusivity regime in China

|
By Mingjia Deng, Zhen Feng, Jessie Xie
| A Matter of Law (Podcast)
Key takeaways China’s new Implementation Measures make regulatory data protection a practical and enforceable exclusivity tool, but only if companies actively secure it at the NDA stage and align global filing strategies with China. A critical, short transitional window applies to pipeline products already under review, requiring filings by the beginning of June 2026, and failure to act within this deadline will result in a permanent loss of data protection rights.
Open in Who Shared Issue with article?
See all 50 licensed articles (55 Total)

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Get in touch with Zhen

Contact Zhen, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified